USV acquires Wellbeing Nutrition for $175M as India’s nutrition market booms

What’s the deal? USVDealroom has a profile for this one. Try Dealroom → has agreed to acquire a 79% stake in direct-to-consumer nutraceutical brand Wellbeing Nutrition in an all-cash deal of about $174.7 million (₹1,583 crore). The Mumbai-based pharmaceutical group will buy shares from founder Avnish ChhabriaDealroom has a profile for this one. Try Dealroom → and existing investors.

The stake includes roughly 35% from Chhabria and about 44% from shareholders including Fireside VenturesDealroom has a profile for this one. Try Dealroom → and Hindustan UnileverDealroom has a profile for this one. Try Dealroom →, which will exit. Chhabria will roll over part of his holding until March 2028, and the current management will continue under USV’s oversight.

Founded in 2019, Wellbeing Nutrition sells vitamins and mineral supplements online and through retail outlets. It has raised more than $12 million to date.

Why now? The acquisition marks USV’s push beyond prescription drugs into preventive and lifestyle-focused wellness. Founded in 1961, USV is known for medicines such as Ecosprin and Tazloc.

What could go wrong? The nutraceutical market is crowded, with legacy players and newer direct-to-consumer startups competing for share.

Integrating a consumer wellness brand into a traditional pharmaceutical group may prove complex. Consumer supplement demand can also be trend-driven, adding volatility.

The signal: The $174.7 million (₹1,583 crore) deal highlights how established pharmaceutical companies are moving into preventive health. As wellness spending grows, drugmakers are seeking recurring consumer revenue beyond prescriptions.

The transaction also signals consolidation in India’s direct-to-consumer nutrition market, with strategic buyers stepping in as venture funding slows.

Sources:
Inc42
The Economic Times
Entrackr
Business Standard
Financial Express
Outlook Business

J.V.